Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trial.
Saved in:
| Title: | Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trial. |
|---|---|
| Authors: | Sullivan J; University of California, San Francisco, San Francisco, California, USA., Lagae L; Department of Pediatric Neurology, University of Leuven, Leuven, Belgium., Cross JH; University College London, National Institute for Health and Care Research Biomedical Research Centre, Great Ormond Street Institute of Child Health, London, UK., Devinsky O; New York University Langone Medical Center, New York, New York, USA., Guerrini R; Meyer Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Florence, Italy., Knupp KG; University of Colorado, Children's Hospital Colorado, Aurora, Colorado, USA., Laux L; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Nikanorova M; Danish Epilepsy Center, Dianalund, Denmark., Polster T; Department of Epileptology (Krankenhaus Mara, Bethel Epilepsy Center), Bielefeld University Medical School, Bielefeld, Germany., Talwar D; University of Arizona Health Sciences Center, Tucson, Arizona, USA., Ceulemans B; Department of Pediatric Neurology, University of Antwerp, Edegem, Belgium., Nabbout R; Hôpital Universitaire Necker-Enfants Malades, Service de Neurologie Pédiatrique, Centre de Référence Épilepsies Rares, Imagine Institute, Institut National de la Santé et de la Recherche Médicale, Unite Mixté de Recherche 1163, Paris Descartes University, Paris, France., Farfel GM; Zogenix, Inc., Emeryville, California, USA., Galer BS; Zogenix, Inc., Emeryville, California, USA., Gammaitoni AR; Zogenix, Inc., Emeryville, California, USA., Lock M; Consultant biostatistician based in Haiku, Haiku, Hawaii, USA., Agarwal A; Zogenix, Inc., Emeryville, California, USA., Scheffer IE; University of Melbourne, Austin Health and Royal Children's Hospital, Melbourne, Victoria, Australia. |
| Corporate Authors: | FAiRE DS Study Group |
| Source: | Epilepsia [Epilepsia] 2023 Oct; Vol. 64 (10), pp. 2653-2666. Date of Electronic Publication: 2023 Aug 17. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
